1 June 2018

Three RIMLS researchers received each 800,000 euros to develop an innovative research project and to build up their own research group. NWO (The Netherlands Organisation for Scientific Research) is awarding the Vidi grant as part of the Innovational Research Incentives Scheme.

Vidi is aimed at excellent researchers who have been producing successful research for a number of years since obtaining their PhD. These academics are among the best 10 to 20 percent in their field. A Vidi will allow them to conduct research for a period of five years. In this way, NWO stimulates curiosity-driven and innovative research.

Information about the RIMLS scientists and their research is given below.

How to read the genome

Simon van Heeringen (FNWI), theme Cancer development and immune defense.
A fertilized egg cell develops into a complete organism with many different cell types. How is this encoded in the genome? Biologists will compare the development of different animals. Using ‘big data’ they will train computer algorithms to understand cellular decisions. This knowledge will be essential for regenerative medicine.

Why do healthy people die of the flu?

Frank van de Veerdonk, theme Infectious diseases and global health
A pandemic is inevitable and will cost millions of lives including many healthy adults. Deadly complications of the flu are fungal infection or a life-threatening inflammatory response. This research will identify why these complications happen and can lead to treatment that can save lives during a severe flu season.

A microchip-based toolbox to treat osteoporosis

Alireza Dolatshahi-Pirouz, theme Reconstructive and regenerative medicine
Due to the aging population new innovations are needed for dealing with osteoporosis the most common disability among today’s elderly. Regenerative medicine can address this challenge through hydrogel- based stem cell therapies. The goal is to develop a toolbox for testing thousands of such therapies in a single experiment.
 

Related news items


Radboudumc Master Prize for Mark van Goor

18 June 2019

Mark van Goor, theme Renal disorders, received the Radboudumc Master Prize for his MSc thesis entitled “High-resolution structure of the renal calcium channel TRPV5 revealed with cryo-EM”, which was based on his internship at the lab of Prof. Yifan Cheng, USA.

read more

Exome sequencing in routine diagnostics: a generic test for 254 patients with primary immunodeficiencies

18 June 2019

Exome sequencing may provide a genetic diagnosis in a significant number of patients in a single genetic test. Alexander Hoischen and Mihai Netea, theme Infectious diseases and global health, and colleagues, published their results in Genome Medicine.

read more

Lowering cholesterol is not enough to reduce hyperactivity of the immune system

14 June 2019

In Cell Metabolism, Siroon Bekkering, theme Vascular damage, and colleagues, provides a novel potential explanation for the residual cardiovascular risk, related to persistent activation of the immune system in patients with hypercholesterolemia who are treated with statins.

read more

A warm welcome for the new forces at RIMLS

13 June 2019

RIMLS is now on full strength by welcoming new colleagues. Let us introduce them to you and find out what they can do for you.

read more

New cause for vaginal yeast infections discovered

13 June 2019

Martin Jaeger, theme Infectious diseases and global health, and colleagues, identified SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis. Their findings were published in Science Translational Medicine.

read more

Internal KWF review procedure 2020

13 June 2019

In agreement with the existing policy the research board and Radboud Center for Oncology have decided to continue with the mandatory internal review procedure for KWF grant applications.

read more